Biotech Extremes Asymmetry
Definition
Framework that biotech returns are highly dispersed because the core technology usually fails, so a few big winners drive outcomes and investors need specialized diligence and diversification.
Cast within
No topic-region cast yet — this appears once Biotech Extremes Asymmetry's compiled claims are aligned into a topic region's argument tree.
Claims mentioning Biotech Extremes Asymmetry (2)
Your notes
Loading notes...